APP and Alzheimer disease: Recently, a study reported that intraperitoneally injected triptolide increased hippocampal neuroligin-1 (a cell adhesion protein, located on the excitatory postsynaptic membrane) expression in the APP/PS1 model of AD through epigenetic mechanisms (Lu et al., 2019).